Incyte (INCY) EVP receives 8,911-share RSU award vesting over 4 years

Rhea-AI Filing Summary

Incyte Corporation executive Heeson Lee reported a stock-based compensation grant. On January 16, 2026, Lee received 8,911 shares of common stock, awarded in the form of restricted stock units (RSUs) at a price of $0 per share.

The RSUs will vest 25% each year over four years and can be settled only in shares of Incyte common stock on a one-for-one basis. After this grant, Lee beneficially owns 38,152 shares of common stock, including an aggregate of 35,078 shares underlying previously reported RSUs that have not yet vested.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Heeson Lee

Role EVP, Head of Incyte Intl

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,911	$0.00	--

Holdings After Transaction: Common Stock — 38,152 shares (Direct)

Footnotes (1)

1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. Including the January 16, 2026 grant, this includes an aggregate of 35,078 shares of common stock issuable pursuant to previously reported RSUs that have not vested.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heeson Lee

(Last) (First) (Middle)

1801 AUGUSTINE CUT-OFF

(Street)

WILMINGTON DE 19803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Head of Incyte Intl

3. Date of Earliest Transaction (Month/Day/Year)
01/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/16/2026		A		8,911(1)	A	$0	38,152(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

2. Including the January 16, 2026 grant, this includes an aggregate of 35,078 shares of common stock issuable pursuant to previously reported RSUs that have not vested.

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	01/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did INCYTE CORP (INCY) report for Heeson Lee?

Incyte reported that EVP, Head of Incyte Intl Heeson Lee received an award of 8,911 shares of common stock on January 16, 2026, recorded as an acquisition at a price of $0 per share in the form of restricted stock units (RSUs).

How do the new RSUs granted to Heeson Lee at INCYTE CORP (INCY) vest?

The filing states that the 8,911 RSUs granted to Heeson Lee will vest 25% annually over four years, and each RSU may be settled only for one share of Incyte common stock.

How many INCYTE CORP (INCY) shares does Heeson Lee beneficially own after this Form 4?

Following the reported transaction, Heeson Lee beneficially owns 38,152 shares of Incyte common stock, as shown in the Form 4 after the January 16, 2026 grant.

How many unvested RSU shares does Heeson Lee hold at INCYTE CORP (INCY)?

The footnotes explain that, including the January 16, 2026 grant, Heeson Lee has an aggregate of 35,078 shares of common stock issuable pursuant to previously reported RSUs that have not vested.

Was the INCYTE CORP (INCY) Form 4 transaction direct or indirect for Heeson Lee?

The Form 4 lists the ownership form as Direct (D) for the 38,152 shares beneficially owned following the transaction, with no separate indirect ownership entity disclosed in the footnotes.

What role does Heeson Lee hold at INCYTE CORP (INCY)?

According to the filing, Heeson Lee is an officer of Incyte, serving as EVP, Head of Incyte Intl, and is not listed as a director or 10% owner.